Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-072655
Filing Date
2020-06-12
Accepted
2020-06-12 08:12:05
Documents
4
Effectiveness Date
2020-06-12

Document Format Files

Seq Description Document Type Size
1 S-8 tm2022158d1_s8.htm S-8 47500
2 EXHIBIT 5.1 tm2022158d1_ex5-1.htm EX-5.1 8321
3 EXHIBIT 23.2 tm2022158d1_ex23-2.htm EX-23.2 2525
4 GRAPHIC tm2022158d1_ex5-1img001.jpg GRAPHIC 1611
  Complete submission text file 0001104659-20-072655.txt   61779
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239114 | Film No.: 20958918
SIC: 2834 Pharmaceutical Preparations